Vapor-induced phase transformations in docetaxel

AAPS PharmSciTech

Volumn 13, Issue 2, 2012, Pages 548-555

  Tatini, Lakshmi Kumar ^a   Krishna Reddy, K V S R ^a   Someswara Rao, N ^b  

^a Analytical Development   (India)

^b ANDHRA UNIVERSITY   (India)

Author keywords

docetaxel anhydrous; FT IR spectroscopy; nuclear magnetic spectroscopy; p XRD; thermal analysis; vapor induced transformations

Indexed keywords

ALCOHOL; DOCETAXEL; METHANOL; WATER;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DIFFERENTIAL SCANNING CALORIMETRY; ENTHALPY; ENVIRONMENTAL TEMPERATURE; HYDRATION; HYDROGEN BOND; INFRARED SPECTROSCOPY; PHASE TRANSITION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO; SOLID STATE; SOLVATE; SOLVATION; STOICHIOMETRY; THERMOGRAVIMETRY; VAPOR; X RAY POWDER DIFFRACTION;

ANTINEOPLASTIC AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLOGRAPHY, X-RAY; ETHANOL; MAGNETIC RESONANCE SPECTROSCOPY; METHANOL; MOLECULAR STRUCTURE; PHASE TRANSITION; POWDER DIFFRACTION; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TAXOIDS; TECHNOLOGY, PHARMACEUTICAL; THERMOGRAVIMETRY; VOLATILIZATION; WATER;

EID: 84862889376     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-012-9774-7     Document Type: Article

References (21)

1. International Conference on Harmonization (ICH): guideline specifications Q6A, 1999.
2. Office of the Federal Register. Q6A-specifications. Test procedures and acceptance criteria for new drug substances and drug products: new chemical substances. Federal Register, 65(251), 83041-63 (2000).
3. Brittain HG. Polymorphism in pharmaceutical solids. New York: Marcel Dekker; 1999.
4. SY Tsai SC Kuo SY Lin 1993 Physicochemical characterization of 9,10-anthraquinone-2-carboxylic acid J Pharm Sci 82 1250 1254 8308705 10.1002/jps.2600821213 1:STN:280:DyaK2c7ktFOisw%3D%3D (Pubitemid 23354146)
5. LS Wu G Torosian K Sigvardson C Gerard MA Hussain 1994 Investigation of moricizine hydrochloride polymorphs J Pharm Sci 83 1404 1406 7884659 10.1002/jps.2600831008 1:CAS:528:DyaK2cXlvVKqt70%3D (Pubitemid 24315273)
6. A Burger AW Ratz 1988 Polymorphism and dissolution behavior of midodrine hydrochloride Pharm Ind 50 1186 1189 1:CAS:528:DyaL1MXhtlCkug%3D%3D (Pubitemid 18260604)
7. Shanker RF. Micro-techniques for physicochemical measurements. AAPS Symposium on Pharmaceutical Development Contributions During the Drug Discovery Process, Miami Beach, Florida, 1995.
8. M Otsuka Y Matsuda 1993 Effects of environmental temperature and compression energy on polymorphic transformation during tableting Drug Dev Ind Pharm 19 2241 2269 10.3109/03639049309047191 1:CAS:528:DyaK2cXhsVyiug%3D%3D (Pubitemid 23337894)
9. M Yoshioka BC Hancock G Zografi 1994 Crystallization of indomethacin from the amorphous state below and above its glass transition temperature J Pharm Sci 83 1700 1705 7891297 10.1002/jps.2600831211 1:CAS:528:DyaK2cXms1entrY%3D
10. WL Rocco 1994 Solid state characterization of stanozolol Drug Dev Ind Pharm 20 1831 1849 10.3109/03639049409050212 1:CAS:528:DyaK2cXksVamu7s%3D (Pubitemid 24202682)
11. M Otsuka K Otsuka N Kaneniwa 1994 Relation between polymorphic transformation pathway during grinding and the physicochemical properties of bulk powders for pharmaceutical preparations Drug Dev Ind Pharm 20 1649 1660 10.3109/03639049409050205 1:CAS:528:DyaK2cXjtlSqtLc%3D (Pubitemid 24173005)
12. K Fujii Y Ashida KDM Harris 2009 Vapour induced crystalline transformation investigated by ab initio powder X-ray diffraction analysis Cryst Growth Des 9 1201 1207 10.1021/cg801142p 1:CAS:528:DC%2BD1cXhsFals7fJ
13. KR Khankari DJW Grant 1995 Pharmaceutical hydrates Thermochim Acta 248 61 79 10.1016/0040-6031(94)01952-D 1:CAS:528:DyaK2MXivVOrtrw%3D
14. S Byrn R Pfeiffer M Ganey C Hoiberg G Poochilian 1995 Pharmaceutical solids: a strategic approach to regulatory considerations Pharm Res 12 945 954 7494814 10.1023/A:1016241927429 1:CAS:528:DyaK2MXmvFClu7c%3D
15. S Nakamatsu S Toyota W Jones F Toda 2005 The important role of solvent vapor in an organic solid state reaction Chem Commun 62 3808 3810 10.1039/b503922c (Pubitemid 41139747)
16. T Lakshmi Kumar P Vishweshwar 2009 Host-guest complexes of docetaxel, an anti-cancer drug J Incl Phenom Macrocycl Chem 66 261 269 10.1007/s10847-009- 9606-x
17. RS Chao KC Vail 1987 Polymorphism of 1,2-dihydro-6-neopentyl-2- oxonicotinic acid: characterization, interconversion and quantitation J Pharm Res 4 429 432 10.1023/A:1016498731952 1:CAS:528:DyaL1cXis1yqtA%3D%3D (Pubitemid 18010576)
18. Liao YX, HO MF, Chen SP, Lin CH, Lin YL, Hsiao TY. Crystalline forms of docetaxel and process for preparation thereof. US 2008/108693.
19. HG Brittain 1997 Spectral methods for the characterization of polymorphs and solvates J Pharm Sci 86 405 412 9109040 10.1021/js960238e 1:CAS:528:DyaK2sXhslamt7g%3D (Pubitemid 27154753)
20. Brittain HG. Physical characterization of pharmaceutical solids. New York: Marcel Dekker; 1995.
21. 13C NMR spectroscopy and powder X-ray diffraction for analyzing mixtures of polymorphs of neotame Anal Chem 71 3325 3331 10.1021/ac9902446 1:CAS:528:DyaK1MXkt1yhsbk%3D (Pubitemid 29387973)